SSRI Antidepressant Medications: Adverse Effects and Tolerability
about
Is increased antidepressant exposure a contributory factor to the obesity pandemic?The neuroscience and context of adolescent depressionIdiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorderChallenging received wisdom: antidepressants and the placebo effectConsistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depressionSystematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis.Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials.A review of vilazodone, serotonin, and major depressive disorder.Modulating Oxidative Stress Relieves Stress-Induced Behavioral and Cognitive Impairments in Rats.Role and rationale for the use of milnacipran in the management of fibromyalgiaAdverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individualsVoltammetric and mathematical evidence for dual transport mediation of serotonin clearance in vivoDiscovery of novel selective serotonin reuptake inhibitors through development of a protein-based pharmacophore.Tolerability and safety of fluvoxamine and other antidepressants.Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies.Acupuncture/electroacupuncture enhances anti-depressant effect of Seroxat: the Symptom Checklist-90 scores.SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and AdolescentsDiscovery of novel-scaffold monoamine transporter ligands via in silico screening with the S1 pocket of the serotonin transporterA review of current evidence for vilazodone in major depressive disorder.Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials.Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case reportEfficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder.Alteration in brain-derived neurotrophic factor (BDNF) after treatment of mice with herbal mixture containing Euphoria longana, Houttuynia cordata and Dioscorea japonicaModerate treadmill exercise rescues anxiety and depression-like behavior as well as memory impairment in a rat model of posttraumatic stress disorderEarly adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.Sexual function improvement in association with serum leptin level elevation in patients with premature ejaculation following sertraline treatment: a preliminary observationFunctional and developmental identification of a molecular subtype of brain serotonergic neuron specialized to regulate breathing dynamics.Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.Identification of a novel selective serotonin reuptake inhibitor by coupling monoamine transporter-based virtual screening and rational molecular hybridizationGlucose tolerance in patients with narcolepsy.Assessing Sexual Function of Patients Before Initiating SSRI Therapy.Effect of comedication of bupropion and other antidepressants on body mass index.Treatment-resistant posttraumatic stress disorder: strategies for intervention.Evaluation of the efficacy and safety of vilazodone for treating major depressive disorderBipolar depression: a new role for atypical antipsychotics?Prediction of Treatment Outcome in Patients with Obsessive-Compulsive Disorder with Low-Resolution Brain Electromagnetic Tomography: A Prospective EEG StudyOveruse of antidepressant drugs for the treatment of depression.Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression.Sexual touching and difficulties with sexual arousal and orgasm among U.S. older adults.
P2860
Q26765430-EBB04B03-55E5-48FF-B655-4A41B4416666Q28084332-5B5614CD-3E8B-4B57-AF08-9073C95248ABQ28265427-51FF36CA-A584-46B9-8514-CD493D163293Q28474068-E473052C-DDC1-454E-9A03-DF31FB740E78Q28550946-CE17C3A4-E2E0-4F6E-A7F3-24D71309A886Q30490929-F110EE6A-FDE1-4C84-9584-61C4029AF6B0Q30990488-2B064189-F4D3-433C-A142-CAF12E3DA153Q33721197-9EDB18EC-41DD-4CDD-9E68-B24F2EE1BF69Q33858253-9991D5B4-A2D0-443A-9405-A1D53A6367B3Q33881505-EC16B94E-DBBA-46DB-8957-C0319494F956Q33906501-32643529-EFA0-4B66-805B-B1ECFC476490Q33934982-2BADA202-F574-457A-8F69-79D3147A0BF9Q33990707-C052604E-1F5D-4A48-8506-CA4F3CDB8945Q33995120-4F6ECA9E-E008-4F4E-AAEC-CD004146A4ECQ34092254-516403CD-2517-4E3E-81AC-CD59CF2AB164Q34095712-2F4D52A9-32EF-4B46-AD86-B2EDEE0D413DQ34162104-11DA655F-FC0C-45C6-9F8B-43BE7D558047Q34249476-BC352025-48C7-416F-98F8-77BFDE12DFFEQ34338647-20E75288-3B76-4690-98D6-2ABF9CA21354Q34384552-2F6839A8-B32E-48F8-8C5B-4B59CC393A62Q34389452-7E7BD18E-F927-4BA1-BD60-FCB6972F4DC2Q34419374-6BD8D9F7-2F92-43B7-804C-0494FC280825Q34579202-7FA3D47E-AD12-4B61-9ED6-DB2FDE70A7E1Q34720817-14834886-C024-4A08-A82F-77607C2EDBD2Q35053258-405C42B5-1712-4BF1-B5D9-14A3D20A45A4Q35058467-91FF4D08-2C51-408F-949B-921E2336C41EQ35100000-C1EF98C8-4383-448E-B98C-7E6072AD239AQ35153845-78CC31B5-6366-4D14-B701-B08220951515Q35162301-4957ACCD-A943-41B4-B72C-084DB19DEFE9Q35234897-229AA2B3-9A23-4C2F-B936-4D0A311C0AACQ35648378-31AE32A5-2998-41CD-9833-E94AC47C67DAQ35666454-8A27D8C7-8363-4640-8C90-838A8301AC26Q35852531-397F4022-73DE-4F80-A2B1-62D272AC8287Q35901891-10A66E66-8EE8-4F42-9F4A-C74ED78E0EADQ35934859-249DB19B-69B1-4EFA-993C-098CB6A65BA8Q36158827-FFFFF6E3-C5E4-4A0C-85B7-F41C0C73EB6FQ36488474-E888CF2B-C117-4D57-A310-45A83DADCE17Q36544833-CF213F35-7A8F-444B-82B0-4CB35D0D9AA2Q36551469-A57A5078-F5FB-4888-A240-41237272A342Q36659073-F517DA72-E409-40ED-BDE4-5B3D71A2B73E
P2860
SSRI Antidepressant Medications: Adverse Effects and Tolerability
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
SSRI Antidepressant Medications: Adverse Effects and Tolerability
@ast
SSRI Antidepressant Medications: Adverse Effects and Tolerability
@en
SSRI Antidepressant Medications: Adverse Effects and Tolerability
@nl
type
label
SSRI Antidepressant Medications: Adverse Effects and Tolerability
@ast
SSRI Antidepressant Medications: Adverse Effects and Tolerability
@en
SSRI Antidepressant Medications: Adverse Effects and Tolerability
@nl
altLabel
SSRI Antidepressant Medications
@en
prefLabel
SSRI Antidepressant Medications: Adverse Effects and Tolerability
@ast
SSRI Antidepressant Medications: Adverse Effects and Tolerability
@en
SSRI Antidepressant Medications: Adverse Effects and Tolerability
@nl
P2860
P3181
P356
P1476
SSRI Antidepressant Medications
@en
P2093
James M. Ferguson
P2860
P3181
P356
10.4088/PCC.V03N0105
P577
2001-02-01T00:00:00Z